Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
Adam Z, Pour L, Svobodník A, Scudla V, Salajka F, Vytrasová M, Bacovský J, Schützová M, Koza V, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Cahová S, Vránová M, Dostálová V, Kessler P, Walterová L, Meluzínová I, Seifertová N, Sláma O, Büchler T, Krejcí M, Bencíková V, Nykodýmová V, Dusek L, Hájek R; Czech Myeloma Group. Adam Z, et al. Among authors: kessler p. Vnitr Lek. 2002 Mar;48(3):216-29. Vnitr Lek. 2002. PMID: 11968583 Clinical Trial. Czech.
[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J. Krejcí M, et al. Among authors: kessler p. Vnitr Lek. 2001 Sep;47 Suppl 1:40-7. Vnitr Lek. 2001. PMID: 11693062 Clinical Trial. Czech.
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.
Kessler P, Pour L, Gregora E, Zemanova M, Penka M, Brejcha M, Adam Z, Bacovsky J, Fenclova M, Frankova H, Hausdorf P, Walterova L, Heinzova V, Holikova M, Krejci M, Kubackova K, Langrova E, Maisnar V, Meluzinova I, Stavarova Y, Straub J, Scudla V, Gumulec J, Ullrychova J, Hajek R; Czech Myeloma Group. Kessler P, et al. Klin Onkol. 2011;24(4):281-6. Klin Onkol. 2011. PMID: 21905619
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Minarik J, Pavlicek P, Pour L, Pika T, Maisnar V, Spicka I, Jarkovsky J, Krejci M, Bacovsky J, Radocha J, Straub J, Kessler P, Wrobel M, Walterova L, Sykora M, Obernauerova J, Brozova L, Gregora E, Adamova D, Gumulec J, Adam Z, Scudla V, Hajek R; Czech Myeloma Group. Minarik J, et al. Among authors: kessler p. PLoS One. 2015 Apr 14;10(4):e0123866. doi: 10.1371/journal.pone.0123866. eCollection 2015. PLoS One. 2015. PMID: 25875484 Free PMC article.
Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies.
Hájek R, Jarkovsky J, Maisnar V, Pour L, Špička I, Minařík J, Gregora E, Kessler P, Sýkora M, Fraňková H, Campioni M, DeCosta L, Treur M, Gonzalez-McQuire S, Bouwmeester W. Hájek R, et al. Among authors: kessler p. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e219-e240. doi: 10.1016/j.clml.2018.04.003. Epub 2018 Apr 17. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29793653
[Bleeding complications of anticoagulant therapy].
Gumulec J, Kessler P, Procházka V, Brejcha M, Penka M, Zänger M, Machytka E, Klement P. Gumulec J, et al. Among authors: kessler p. Vnitr Lek. 2009 Mar;55(3):277-89. Vnitr Lek. 2009. PMID: 19378860 Review. Czech.
Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.
Jelínek T, Maisnar V, Pour L, Špička I, Minařík J, Gregora E, Kessler P, Sýkora M, Fraňková H, Adamová D, Wróbel M, Mikula P, Jarkovský J, Diels J, Gatopoulou X, Veselá Š, Besson H, Brožová L, Ito T, Hájek R. Jelínek T, et al. Among authors: kessler p. Curr Med Res Opin. 2018 May;34(5):775-783. doi: 10.1080/03007995.2017.1410121. Epub 2018 Feb 15. Curr Med Res Opin. 2018. PMID: 29172760
[Hemorrhagic complications during warfarin treatment].
Gumulec J, Kessler P, Penka M, Klodová D, Králová S, Brejcha M, Wróbel M, Sumná E, Blatný J, Klaricová K, Riedlová P, Lasota Z. Gumulec J, et al. Among authors: kessler p. Vnitr Lek. 2006 Mar;52 Suppl 1:79-91. Vnitr Lek. 2006. PMID: 16637455 Review. Czech.
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
Minarik J, Pika T, Radocha J, Jungova A, Straub J, Jelinek T, Pour L, Pavlicek P, Mistrik M, Brozova L, Krhovska P, Machalkova K, Jindra P, Spicka I, Plonkova H, Stork M, Bacovsky J, Capkova L, Sykora M, Kessler P, Stejskal L, Heindorfer A, Ullrychova J, Skacel T, Maisnar V, Hajek R. Minarik J, et al. Among authors: kessler p. BMC Cancer. 2021 Jan 15;21(1):73. doi: 10.1186/s12885-020-07732-1. BMC Cancer. 2021. PMID: 33451293 Free PMC article.
524 results